OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+1.81%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$326M
AUM Growth
+$326M
(-34%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-50.86%
Top 10 Holdings %
Top 10 Hldgs %
94.39%
Holding
31
New
5
Increased
5
Reduced
10
Closed
6
Top Buys
| 1 |
Moderna
MRNA
|
$12.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$11.7M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
$3.6M |
| 4 |
GeneDx Holdings
WGS
|
$3.33M |
| 5 |
IMMP
Immutep
IMMP
|
$1.18M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$120M |
| 2 |
QuidelOrtho
QDEL
|
$20.3M |
| 3 |
ARK Innovation ETF
ARKK
|
$16.6M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$11.8M |
| 5 |
AGEN
Agenus
AGEN
|
$7.86M |
Sector Composition
| 1 | Healthcare | 98.7% |
| 2 | Energy | 0.18% |
| 3 | Industrials | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Centene
CNC
$14.3B
| – | – |
0
| – | – |
|
27
ImmunityBio
IBRX
$2.21B
| – | – |
-400,013
| Closed | -$2.24M |
|
28
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$647M
| – | – |
0
| – | – |
|
29
Pfizer
PFE
$141B
| – | – |
0
| – | – |
|
30
Performance Technologies
PTIX
$3.13M
| – | – |
-20,000
| Closed | -$16K |
|
|
ATRS
31
DELISTED
Antares Pharma, Inc.
ATRS
| – | – |
-1,720,000
| Closed | -$7.05M |
|